WKN DE: A2QDFS / ISIN: US86627T1088

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (groß)	News + Adhoc	Bilanz/GuV	Termine	Zertifikate	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Optionsscheine	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV	Knock-Outs
Historisch	Analysen

Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Historisch

News + Analysen
News + Adhoc
Analysen
Kursziele

Fundamental
Bilanz/GuV
Schätzungen
Dividende/GV
Analysen

Unternehmen
Termine
Profil

zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs

Summit Therapeutics Times and Sales (NAS)

Zeit	Kurs	Umsatz (Stk)
20:45:55	20,580	25
20:45:55	20,570	75
20:45:55	20,570	255
20:45:52	20,560	1
20:45:52	20,560	100
20:45:52	20,570	1
20:45:52	20,570	1
20:45:52	20,570	1
20:45:42	20,570	1
20:45:33	20,570	4
20:45:33	20,570	34
20:45:33	20,570	60
20:45:33	20,570	70
20:45:33	20,570	1
20:45:33	20,570	24
20:45:31	20,580	1
20:45:31	20,580	3
20:45:31	20,580	50
20:44:35	20,600	100
20:44:35	20,600	200
20:44:33	20,590	90
20:44:33	20,590	100
20:44:33	20,590	100
20:44:33	20,590	44
20:44:33	20,590	34
20:44:33	20,600	3
20:44:33	20,600	100
20:44:33	20,600	27
20:44:33	20,600	100
20:44:33	20,600	70
20:44:33	20,580	100
20:44:33	20,600	30
20:44:33	20,600	99
20:44:33	20,600	5
20:44:33	20,600	5

Kursrückgang	Kursanstieg	keine Kursänderung
(Balkenlänge beschreibt das Umsatzvolumen)

Analysen zu Summit Therapeutics Inc Registered Shs

Weitere Meldungen

18:14		Trade Desk Customers Buying Amazon Ads Is 'Not Troubling,' Says Bullish Analyst
18:11		Trump Has Power, a Big Megaphone and Billions to Spend. So Does Musk.
18:09		DocuSign Posts Beat-And-Raise Quarter; Stock Tanks Almost 20%
18:09		FuelCell (FCEL) Q2 2025 Earnings Call Transcript
18:08		Why Shares of REV Group Are Charging Higher This Week
18:05		Why Docusign Stock Got Devastated Today
18:03		Record $3.3 Trillion Global Energy Investment: Which Solar Stocks Could Soak Up The Sun?
18:01		Spotify Technology's Options: A Look at What the Big Money is Thinking
18:01		Broadcom's Quiet War On Nvidia: CEO Touts Custom AI Chips, Ethernet Over NVLink—'No Reason To Create A New Standard'
18:00		What Does the Market Think About Grand Canyon Education?
18:00		$100 Invested In This Stock 10 Years Ago Would Be Worth This Much Today
18:00		US fiscal policy is going off the rails — and nobody seems to want to fix it
18:00		US fiscal policy is going off the rails — and nobody seems to want to fix it
17:54		BNP to cut 200 branches by end of 2026 to kick off retail revamp
17:52		Why Concrete Pumping Stock Is Down Big Today
17:52		Trump Cheers Strong Jobs Data, Renews Attack On Fed's Powell: Rates 'Should Be Much Lower'
17:51		Tesla Stock Faces 'Demand/Brand Issues' In US, Competition In China: Analyst Lowers Delivery Estimates
17:51		How astrology is helping Americans invest, save and spend: ‘Bitcoin is a Capricorn’
17:45		DocuSign Shares Are Falling Friday: What's Going On?
17:45		Here's How Much $100 Invested In S&P Global 10 Years Ago Would Be Worth Today
17:42		NIO Stock Volatile After Mixed Q1 Earnings, Cost Cuts And Global Expansion In Focus
17:38		Blockchain's AWS Moment Is Coming, Says WisdomTree's Jason Guthrie
17:37		Zscaler and Ulta Beauty Report Results; the Market Experiences Moods
17:33		Pony.ai Begins Testing Futuristic Robotaxis In China, Mass Rollout Could Be Next
17:30		Here's How Much $100 Invested In AptarGroup 20 Years Ago Would Be Worth Today
17:29		It’s time for private equity to go back to basics
17:24		Why Applied Digital (APLD) Stock Hit A New All-Time High Today
17:22		Broadcom AI Revenue Soars in Q2 2025
17:21		Shiba Inu Slides 4.5% On The Week: Why Is It Going Down?
17:15		Here’s what to know.
17:15		$1000 Invested In This Stock 5 Years Ago Would Be Worth This Much Today
17:11		Arcutis Unveils Long-Term Efficacy, Safety For Zoryve Cream In Pediatric Patients With Atopic Dermatitis
17:11		Braze Analysts Slash Their Forecasts After Q1 Earnings
17:10		Why Broadcom Stock Slumped Today
17:09		Huize (HUIZ) Q1 2025 Earnings Call Transcript
17:08		Why QXO Stock Is Shooting Higher Today
17:03		Broadcom Stock Is Trading Lower Friday: What's Going On?
17:02		Alibaba Releases New Open-Source AI Models With Multilingual And Code Support
17:01		AI Data Centers Are Eating Electricity — And These 3 Energy Stocks Could Be The Biggest Winners, Says Analyst
17:00		Is EQT Gaining or Losing Market Support?
17:00		How Is The Market Feeling About KLA?
17:00		Is the Market Bullish or Bearish on Fiserv?
17:00		Here's How Much You Would Have Made Owning Ulta Beauty Stock In The Last 15 Years
17:00		Insights Into Amazon.com's Performance Versus Peers In Broadline Retail Sector
17:00		Market Analysis: Apple And Competitors In Technology Hardware, Storage & Peripherals Industry
17:00		In-Depth Analysis: Microsoft Versus Competitors In Software Industry
16:54		Mosaic cuts 2025 phosphate forecast on plant setbacks; shares drop
16:53		Trump's Election Overhaul Faces Major Legal Challenge Over State Rights And Executive Power
16:45		$1000 Invested In Ovintiv 5 Years Ago Would Be Worth This Much Today
16:43		Xcel Brands XELB Q1 2025 Earnings Call Transcript

Zurück | 1 | 2 | Weiter

finanzen.net Apps

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.

JETZT MEHR ERFAHREN

Aktien ATX DAX EuroStoxx 50 Dow Jones NASDAQ 100 Nikkei 225 S&P 500

Weitere Aktien: TY Holdings VIA optronics Manganese X Energy Guyana Goldstrike Orphazyme A-S Unsponsored American Depositary Receipt Repr 1 Sh

Kontakt - Impressum - Werbung

Sitemap - Datenschutz - Disclaimer - AGB - Privatsphäre-Einstellungen

Für die aufgeführten Inhalte kann keine Gewährleistung für die Vollständigkeit, Richtigkeit und Genauigkeit übernommen werden.
Kursinformationen von SIX Financial Information Deutschland GmbH. Verzögerung 15 Min. (Nasdaq, NYSE: 20 Min.).
© 1999-2025 finanzen.net GmbH

*Werbehinweise: Die Billigung des Basisprospekts durch die Bundesanstalt für Finanzdienstleistungsaufsicht ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.

⁵Hinweis zu Plus500: 82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren. Plus500UK Ltd ist zugelassen und reguliert durch Financial Conduct Authority (FRN 509909). Plus500CY Ltd authorized & regulated by CySEC (#250/14).

Währungsrechner News Devisen Dollarkurs Aktienkurse Bitcoin Rohstoffe Fonds

Portfolioname: Watchlistname:
Portfolio:
Name:
Typ:
ISIN:
Börse:
Anzahl:
Aktueller Kurs:
Kurszeit:
Kaufpreis:
Kaufdatum:	06.06.2025 21:04
Kaufwert:	EUR
	Hinzufügen Speichern

Summit Therapeutics Aktie

WKN DE: A2QDFS / ISIN: US86627T1088

Summit Therapeutics Times and Sales (NAS)

Analysen zu Summit Therapeutics Inc Registered Shs

Weitere Meldungen